Product Information

TERAZOSIN 2 MG CAPSULE is a generic product labeled by Jubilant Cadista Pharmaceuticals Inc., priced at $0.1133 per EA under NDC 59746038406. Its NADAC has been published 678 times since Nov 28, 2013.

FDA first approved this application on Dec 20, 2004. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

TERAZOSIN 2 MG CAPSULE

Terazosin Hydrochloride
$0.1133per EA

Strength

2 mg/1

NDC

59746038406

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

TERAZOSIN HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA075317

FDA Approved

12/20/2004

TE Code

AB

On Market Since

12/20/2004

Pharmacological Classes

Adrenergic alpha-Antagonists
alpha-Adrenergic Blocker

Price Statistics

The NADAC for TERAZOSIN 2 MG CAPSULE has been published 678 times since Nov 28, 2013, and over the history we have for it it has risen 89.5%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1133 per EA
All-time high$0.1648 (Oct 14, 2020)
All-time low$0.0579 (Aug 19, 2015)
52-week high$0.1190
52-week low$0.1029
Median price$0.1307
Average price$0.1153
Largest weekly change+46.4% (Jan 17, 2018)
Weeks tracked678
Tracking sinceNov 28, 2013

Price History

1W

+6.0%

1M

+7.4%

3M

+10.1%

6M

+0.7%

1Y

-6.1%

3Y

-21.9%

5Y

-22.7%

All

+89.5%

Generic Alternatives

The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 44% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of TERAZOSIN 2 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for TERAZOSIN 2 MG CAPSULE, manufactured by Jubilant Cadista Pharmaceuticals Inc., is $0.1133 per EA (NDC 59746038406), effective Nov 18, 2026.

How has the price of TERAZOSIN 2 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for TERAZOSIN 2 MG CAPSULE has risen 89.5%. It has been tracked across 678 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for TERAZOSIN 2 MG CAPSULE?

Since Nov 28, 2013, the NADAC for TERAZOSIN 2 MG CAPSULE has ranged from a low of $0.0579 (Aug 19, 2015) to a high of $0.1648 (Oct 14, 2020), with a median of $0.1307 per EA.

Are there cheaper alternatives to TERAZOSIN 2 MG CAPSULE?

Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, TERAZOSIN 2 MG CAPSULE, is $0.0638 per EA — about 44% below TERAZOSIN 2 MG CAPSULE.

Who manufactures TERAZOSIN 2 MG CAPSULE?

TERAZOSIN 2 MG CAPSULE (NDC 59746038406) is labeled by Jubilant Cadista Pharmaceuticals Inc., and CMS classifies it as a generic product.